Peix A, García B

Language: Spanish
References: 21
Page: 78-81
PDF size: 62.24 Kb.

ABSTRACT

Cardiovascular diseases are the leading cause of death worldwide, and a health problem in low- and middle-income as well as high-income countries. They also constitute the main cause of death in Latin America, with ischemic heart disease as the principal cause in most countries of the region. In Cuba, heart disease is the first cause of death, followed by cancer and stroke. In its 2030 Agenda for Sustainable Development, the UN recognizes the importance of chronic non-communicable diseases, including cardiovascular diseases.
Cuba has participated actively as lead partner in design and implementation of the two regional technical cooperation projects conducted over the last six years by the International Atomic Energy Agency to address cardiovascular diseases in Latin American and Caribbean member states. These projects have generated greater interest among participating countries in the use of myocardial perfusion for dilated cardiomyopathy and coronary artery disease compared to other imaging techniques; disseminated knowledge about nuclear cardiology techniques and clinical applications in heart failure and coronary artery disease; and made important contributions to implementing harmonized, appropriate and safe clinical protocols. Cuba’s contribution to the International Atomic Energy Agency’s regional cardiology projects has fostered development of human resources and harmonized protocols both nationally and regionally, and demonstrated the importance of region-based scientific cooperation that ensures greater opportunities and more equitable access to resources. This participation has also accrued important benefits to Cuba’s own nuclear cardiology program.

REFERENCES

1. World Health Organization [Internet]. Geneva: World Health Organization; 2017 May 17. Newsroom. Cardiovascular diseases (CVDs); [updated 2015 Jan; cited 2018 Aug 23]. Available from: https://www.who.int/news-room/fact-sheets/de tail/cardiovascular-diseases-(cvds)

2. Statistics Division of the United Nations Economic Commission for Latin America and the Caribbean (UNECLAC).AnuarioEstadístico de América Latina y el Caribe 2016. Santiago de Chile: United Nations Economic Commission for Latin America and the Caribbean; 2017 Feb. 134 p. Spanish.

3. Lanas F, Serón P, Lanas A. Coronary heart disease and risk factors in Latin America. Glob Heart. 2013 Dec;8(4):341–8.

4. Pan American Health Organization; World Health Organization. Información y Análisis de Salud: Situación de Salud en las Américas: Indicadores Básicos 2015. Washington, DC.: Pan American Health Organization; 2015. Spanish.

5. National Health Statistics and Medical Records Division (CU). Anuario Estadístico de Salud 2017 [Internet]. Havana: Ministry of Public Health (CU); 2018 [cited 2018 Aug 23]. 207 p. Available from: http://bvscuba.sld.cu/anuario-estadistico-de -cuba/. Spanish.

6. United Nations. Sustainable Development Goals [Internet]. New York: United Nations; c2019 [cited 2018 Aug 23]. Available from: https://www.un.org/ sustainabledevelopment/sustainable-develop ment-goals/

7. World Health Organization [Internet]. Geneva: World Health Organization; c2019. Health Topics. Noncommunicable diseases and mental health. Events. Global action plan for the prevention and control of NCDs 2013-2020. Geneva: World Health Organization; [cited 2018 Aug 23]. Available from: http://www.who.int/nmh/events/ ncd_action_plan/en/

8. Cubillos-Garzón LA, Casas JP, Morillo CA, Bautista LE. Congestive heart failure in Latin America: the next epidemic. Am Heart J. 2004 Mar;147(3):412–7.

9. Naja F, Jamrozik K, Dobson AJ. Understanding the ‘epidemic of heart failure’: a systematic review of trends in determinants of heart failure. Eur J Heart Fail. 2009 May;11(5):472–9.

10. Chen J, Normand SL, Wang Y, Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for Medicare bene ciaries, 1998–2008. JAMA. 2011 Oct 19;306(15):1669–78.

11. Bocchi EA. Heart failure in South America. CurrCardiol Rev. 2013 May;9(2):147–56.

12. Peix A, Mesquita CT, Páez D, Pereira CC, Félix R, Gutiérrez C, et al. Nuclear medicine in the management of patients with heart failure: guidance from an expert panel of the International Atomic Energy Agency (IAEA). Nucl Med Commun. 2014 Aug;35(8):818–23.

13. Dorbala S, Ananthasubramaniam K, Armstrong IS, Chareonthaitawee P, De Puey EG, Einstein AJ, et al. Single photon emission computed tomography (SPECT) myocardial perfusion imaging guidelines: instrumentation, acquisition, processing, and interpretation. J Nucl Cardiol. 2018 Oct;25(5):1784–846.

14. Murthy VL, Bateman TM, Beanlands RS, Berman DS, Borges-Neto S, Chareonthaitawee P, et al. Clinical quanti cation of myocardial blood  ow using PET: joint position paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Cardiol. 2018 Feb;25(1):269–97.

15. Peix A, Karthikeyan G, Massardo T, Kalaivani M, Patel C, Pabon LM, et al. Value of intraventriculardyssynchrony assessment by gated-SPECT myocardial perfusion imaging in the management of heart failure patients undergoing cardiac resynchronization therapy (VISION-CRT). J Nucl Cardiol. 2019 Jan 25. DOI: 10.1007/s12350-018- 01589-5. [Epub ahead of print].

16. Páez D, Peix A, Orellana P, Vitola J, Mut F, Gutiérrez C, et al. Current status of nuclear cardiology practice in Latin America and the Caribbean. J Nucl Cardiol. 2017 Feb;24(1):308–16.

17. Peix A, Páez D. Ischemic heart disease in Latin American women current perspective and call to action. J Nucl Cardiol. 2018 Oct 5. DOI: 10.1007/ s12350-018-1459-5. [Epub ahead of print].

18. Berrocal I, Peix A, Mut F, Shaw LJ, Karthikeyan G, Estrada Lobato E, et al. Appropriate use of noninvasive ischemia testing to guide revascularization decision making following acute ST elevation myocardial infarction in Latin American countries: results from an expert panel meeting of the International Atomic Energy Agency. Rev Esp Med Nucl Imagen Mol. 2018 Jul–Aug;37(4):237– 43. English, Spanish.

19. Shaw L, Hachamovitch R, Berman DS, Marwick TH, Lauer MS, Heller GV, et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. J Am Coll Cardiol. 1999 Mar;33(3):661–9.

20. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006 Apr 18;47(8 Suppl):C13–8.

21. Baldassarre LA, Raman SV, Min JK, Mieres JH, Gulati M, Wenger NK, et al. Noninvasive imaging to evaluate women with stable ischemic heart disease. JACC Cardiovasc Imaging. 2016 Apr;9(4):421–35.